Editorial Acesso aberto Revisado por pares

Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities

2010; Taylor & Francis; Volume: 3; Issue: 3 Linguagem: Inglês

10.1586/ehm.10.22

ISSN

1747-4086

Autores

Amanda M. Brandow, Julie A. Panepinto,

Tópico(s)

Epigenetics and DNA Methylation

Resumo

Sickle cell disease (SCD) is the most common inherited blood disorder in the USA, affecting approximately 89,000 Americans or one in 400 African–Americans [1]. SCD is caused by inheritance of the s...

Referência(s)